- Home
- EBC vs ACLX Comparison
EBC vs ACLX Comparison
Compare EBC & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBC
- ACLX
- Stock Information
- Founded
- EBC 1818
- ACLX 2015
- Country
- EBC United States
- ACLX United States
- Employees
- EBC N/A
- ACLX N/A
- Industry
- EBC Accident &Health Insurance
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- EBC Finance
- ACLX Health Care
- Exchange
- EBC Nasdaq
- ACLX Nasdaq
- Market Cap
- EBC 3.5B
- ACLX 3.3B
- IPO Year
- EBC 2020
- ACLX 2022
- Fundamental
- Price
- EBC $16.32
- ACLX $67.96
- Analyst Decision
- EBC Buy
- ACLX Strong Buy
- Analyst Count
- EBC 2
- ACLX 13
- Target Price
- EBC $20.25
- ACLX $110.82
- AVG Volume (30 Days)
- EBC 1.5M
- ACLX 617.2K
- Earning Date
- EBC 04-24-2025
- ACLX 05-08-2025
- Dividend Yield
- EBC 2.87%
- ACLX N/A
- EPS Growth
- EBC N/A
- ACLX N/A
- EPS
- EBC 0.66
- ACLX N/A
- Revenue
- EBC $664,134,000.00
- ACLX $107,936,000.00
- Revenue This Year
- EBC $26.65
- ACLX N/A
- Revenue Next Year
- EBC $7.02
- ACLX $103.84
- P/E Ratio
- EBC $25.38
- ACLX N/A
- Revenue Growth
- EBC 126.97
- ACLX N/A
- 52 Week Low
- EBC $12.22
- ACLX $47.88
- 52 Week High
- EBC $19.40
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- EBC 41.27
- ACLX 47.21
- Support Level
- EBC $16.07
- ACLX $68.56
- Resistance Level
- EBC $17.08
- ACLX $72.68
- Average True Range (ATR)
- EBC 0.36
- ACLX 3.01
- MACD
- EBC 0.09
- ACLX -0.31
- Stochastic Oscillator
- EBC 56.86
- ACLX 18.14
About EBC Eastern Bankshares Inc.
Eastern Bankshares Inc is a commercial bank that caters its products and services to retail, commercial, and small business customers. Its diversified products and services include lending, deposit, wealth management, and insurance products. The company has one operating segment; Banking business which offers a range of banking lending, savings, and small business offerings, and its wealth management and trust operations.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.